ELICIO THERAPEUTICS INC has a total of 20 patent applications. Its first patent ever was published in 2019. It filed its patents most often in Australia, Brazil and Canada. Its main competitors in its focus markets biotechnology, pharmaceuticals and foods and drinks are TERMAN DAVID S, INVESTIG APLICADA S A DE C V and AMPHERA B V.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 2 | |
#2 | Brazil | 2 | |
#3 | Canada | 2 | |
#4 | China | 2 | |
#5 | EPO (European Patent Office) | 2 | |
#6 | Israel | 2 | |
#7 | Republic of Korea | 2 | |
#8 | Singapore | 2 | |
#9 | United States | 2 | |
#10 | WIPO (World Intellectual Property Organization) | 2 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Microorganisms | |
#5 | Enzymes |
# | Name | Total Patents |
---|---|---|
#1 | Steinbuck Martin | 16 |
#2 | Demuth Peter C | 12 |
#3 | Adams Julian | 8 |
#4 | Demuth Peter | 4 |
#5 | Martin Steinbuck | 2 |
#6 | Peter C Demuth | 2 |
#7 | Julian Adams | 1 |
Publication | Filing date | Title |
---|---|---|
BR112020017778A2 | CPG AMPHIFILS AND USES OF THE SAME | |
CN112118847A | Compounds comprising mutated KRAS sequences and lipids and uses thereof |